ArticleCells2019

Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation "MSC-FFM"-Outcome Report of 92 Patients.

Halvard Bonig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.